Key facts
- Notable investors include Unicorn Factory Lisboa, Launch Africa Ventures, SKEMA Entrepreneurs, TASMU Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Clarrio.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Clarrio.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clarrio.ai
Developer of a healthcare AI platform designed to transform real-world data into predictive clinical insights. The company offers AI-powered data aggregation, device-agnostic integration, and real-time risk modeling, enabling healthcare providers, researchers, insurers, and pharmaceutical organizations to make earlier interventions, improve outcomes, and reduce costs.
- Sector
- Healthcare
- HQ
- Marseill, France
- Employees
- 23
- Website
- clarrio.ai/
- Ownership
- Privately Held (backing)
Clarrio.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clarrio.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clarrio.ai in its N-PORT filings yet. We sweep new filings monthly.